An exciting psychedelics update from the land down under: The Medical Research Future Fund (MRFF), under the Australian Government’s Innovative Therapies for Mental Illness Grant, has awarded two Sydney research teams a total of over A$3 million ($2.24 million) to study MDMA and psilocybin therapies for mental illness. This fund is intended to “transform health and medical research and innovation to improve lives, build the economy and contribute to health system sustainability.”
#
#